(Q50527671)

14 March 2018

title

A basic compositional requirement of agents having heparin-like cell-modulating activities. (English)

1 reference

14 March 2018

9

Barnathan ES

1 reference

14 March 2018

author name string

Weisz PB

1

1 reference

14 March 2018

Joullié MM

2

1 reference

14 March 2018

Hunter CM

3

1 reference

14 March 2018

Kumor KM

4

1 reference

14 March 2018

Zhang Z

5

1 reference

14 March 2018

Levine E

6

1 reference

14 March 2018

Macarak E

7

1 reference

14 March 2018

Weiner D

8

1 reference

14 March 2018

language of work or name

English

0 references

publication date

1 July 1997

1 reference

14 March 2018

published in

Biochemical Pharmacology

1 reference

14 March 2018

volume

54

1 reference

14 March 2018

issue

1

1 reference

14 March 2018

page(s)

149-157

1 reference

14 March 2018

Heparin: An Old Drug with a New Paradigm

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

More to "heparin" than anticoagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of Cortisone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Control of angiogenesis with synthetic heparin substitutes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Affinity of fibroblast growth factors for beta-cyclodextrin tetradecasulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Protamine is an inhibitor of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Human endothelial cells: use of heparin in cloning and long-term serial cultivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Inhibition of smooth muscle cell proliferation and experimental angioplasty restenosis by beta-cyclodextrin tetradecasulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Synthetic cyclodextrin derivatives inhibit HIV infection in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Metachromatic activity of heparin and heparin fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Sustained inhibition of intimal thickening. In vitro and in vivo effects of polymeric beta-cyclodextrin sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Tumor Growth and Neovascularization: An Experimental Model Using the Rabbit Cornea 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Suppression by heparin of smooth muscle cell proliferation in injured arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Differential staining of acid glycosaminoglycans (mucopolysaccharides) by alcian blue in salt solutions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

A colorimetric assay for chemical heparin in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Cell-surface glycosaminoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Interactions of N-CAM with heparin-like molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Glycosaminoglycans and Their Binding to Biological Macromolecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Heparin stimulates the synthesis and modifies the sulfation pattern of heparan sulfate proteoglycan from endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Heparin increased cell membrane-associated heparan sulfate proteoglycan in balloon-injured rat carotid artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Clinical applications of heparin-binding growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Binding of heparin on the surface of cultured human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Interaction of heparin with human basic fibroblast growth factor: protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Nature of the interaction of heparin with acidic fibroblast growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Nature of the interaction of growth factors with suramin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Heparin-binding growth factor blockade with pentosan polysulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Detectable Inhibition of Heparin-Binding Growth Factor Activity in Sera From Patients Treated With Pentosan Polysulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Ibisterol sulfate, a novel HIV-inhibitory sulfated sterol from the deep water sponge Topsentia sp.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Sucralfate and soluble sucrose octasulfate bind and stabilize acidic fibroblast growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

Inhibition of binding of basic fibroblast growth factor to low and high affinity receptors by carrageenans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

The non-antithrombotic therapeutic potential of heparin and related heparinoids in cardiovascular diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900157-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(97)00157-3

1 reference

14 March 2018

PubMed ID

9296361

1 reference

14 March 2018